Determining the level of stromal and epithelial cells activity in normal and hyperplastic endometrium of late reproductive and perimenopausal women. 2023

Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
Odessa City Center for Climacteric Problems, Odesa, Ukraine.

Hyperplastic processes of the endometrium (HPE) are a group of benign endometrial and stromal cells that have undergone altered growth. This study aimed to investigate the potential role of hypoxia (as indicated by Hif-1α) and apoptosis markers (p53 and BCL-2) in the development of hyperplastic processes of the endometrium (HPE). Results showed that endometrial cells with atypical hyperplasia had increased levels of Hif-1ɑ, which indicates the presence of endometrial hypoxia and may trigger pathological manifestations. Though this result was not statistically significant, it could be the cause of atypia hyperplasia in the late reproductive period (Hif-1ɑ=1.89±0.09 units) and the perimenopausal period (Hif-1ɑ=2.09±0.07 units). Additionally, the study found that p53 markers were elevated in epithelial cells in the late reproductive period, and similar patterns were observed in the perimenopausal period, with the biggest expression in atypical hyperplasia. The study also found that the high expression of BCL-2 indicator (+++) was less common in late reproductive period women with atypia than those without it (χ2=7.2 p=0.01). A similar situation was observed in women in the perimenopausal period (χ2=4.2 p=0.04). These findings suggest that hypoxia may play a role in the development of HPE, as well as changes in apoptotic markers present in the endometrial tissue.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D004714 Endometrial Hyperplasia Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant. Atypical Endometrial Hyperplasia,Complex Endometrial Hyperplasia,Simple Endometrial Hyperplasia,Atypical Endometrial Hyperplasias,Complex Endometrial Hyperplasias,Endometrial Hyperplasia, Atypical,Endometrial Hyperplasia, Complex,Endometrial Hyperplasia, Simple,Endometrial Hyperplasias,Endometrial Hyperplasias, Atypical,Endometrial Hyperplasias, Complex,Endometrial Hyperplasias, Simple,Hyperplasia, Atypical Endometrial,Hyperplasia, Complex Endometrial,Hyperplasia, Endometrial,Hyperplasia, Simple Endometrial,Hyperplasias, Atypical Endometrial,Hyperplasias, Complex Endometrial,Hyperplasias, Endometrial,Hyperplasias, Simple Endometrial,Simple Endometrial Hyperplasias
D004717 Endometrium The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo. Endometria
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial
D047648 Perimenopause The transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.

Related Publications

Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
April 1994, American journal of obstetrics and gynecology,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
January 1954, Cancer,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
January 2015, Likars'ka sprava,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
April 1984, Journal of clinical pathology,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
June 1988, Gynecologic oncology,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
January 2021, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
February 1968, The Johns Hopkins medical journal,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
August 2004, Analytical and quantitative cytology and histology,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
July 1996, The Journal of pathology,
Zinaida Vasilyvna Chumak, and Volodymyr Victorovich Artyomenko, and Mykola Vitaliiovich Shapoval, and Liudmyla Volodymyrivna Mnih, and Ganna Volodymyrivna Kozhukhar, and Serhii Vasilyovich Derishov
October 1968, American journal of obstetrics and gynecology,
Copied contents to your clipboard!